NEXT
Sign in to follow

The Legal Intelligencer

41 Insurers' Case Against GSK Over Bad Drugs Stands

A group of 41 insurance companies that purchases billions of dollars in adulterated drugs from GlaxoSmithKline can proceed with their Racketeering Influenced and Corrupt Organization Act case against the pharmaceutical giant.
6 minute read

Connecticut Law Tribune

2016 Legal Departments of the Year, Community Outreach Award: Nestlé Waters North America

By | November 09, 2016
Nestlé Waters North America's legal department is heavily committed to charitable and pro bono efforts, including a "corporate citizenship goal," seeking to deepen its involvement in community affairs at the local level. The department pursues that goal via volunteering and contribution. Through August, the department had contributed more than 700 hours for 2016, and is pushing to increase volunteer hours.
11 minute read

Corporate Counsel

In the Beauty Industry, Lawyers Push for Regulatory Overhaul

What's in my beauty products? More than ever before, consumers are demanding an answer to that question. And a growing number of lawyers are helping them get answers.
15 minute read

National Law Journal

U.S. Senator Prods Mylan on EpiPen 'Pay for Delay' Concerns

Sen. Patty Murray wants answers to questions about a settlement with Teva Pharmaceuticals, which applied to the FDA for a generic equivalent for the EpiPen.
8 minute read

National Law Journal

Lawmakers Target FDA Along With Mylan CEO at Congressional EpiPen Hearing

Searching for solutions to the skyrocketing cost of the EpiPen, lawmakers on the House Oversight Committee looked to Mylan chief executive officer Heather Bresch on Wednesday and asked why the pharmaceutical company could not lower the price for the drug delivery device used to treat life-threatening allergic reactions.
14 minute read

New York Law Journal

In re: Kind

By | September 21, 2016
Lawsuit Over Snacks' 'All-Natural' Claims Stayed Pending FDA's Rulemaking Process
3 minute read

Litigation Daily

The Birds, the Bees and the Second Circuit

Hey fellow parents--Are you dreading having The Talk with your son or daughter? No need to rush out and buy 'Our Bodies, Ourselves.' You can just give your kid a copy of an opinion on Friday by the U.S. Court of Appeals for the Second Circuit. It's all pretty much there, thanks to a slightly absurd false advertising suit between two pregnancy test makers.
13 minute read

National Law Journal

EpiPen Maker Responds to Sen. Grassley

A seven-page letter Mylan N.V. sent to Sen. Chuck Grassley, R-Iowa, detailing its justifications for the EpiPen price increases that have brought the company intense scrutiny doesn't provide a "full picture."
4 minute read

Corporate Counsel

Former Firmenich GC on Risk Management Growth

"If you want the legal team to contribute to the company strategy and performance, you need to connect the legal function with the other driving forces of the company," Dominique Graz says in a recent interview. "It is very important to be close to the business, to understand the suppliers' and clients' dynamics."
6 minute read

The Recorder

Covington Expands LA Office as 'Silicon Beach' Takes Shape

Covington & Burling is growing in Los Angeles with an eye toward Silicon Valley work spreading south to L.A.
15 minute read

TRENDING STORIES

Law Pro Logo

Featured Firms

Law Offices of Gary Martin Hays & Associates, P.C.

(470) 294-1674

Law Offices of Mark E. Salomone

(857) 444-6468

Smith & Hassler

(713) 739-1250

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Leveraging Technology to Improve Employee Engagement and Client Satisfaction

    Brought to you by CARET Legal

    Download Now

  • How to Choose Your Legal Operations Software: Key Considerations and Expert Tips

    Brought to you by DiliTrust

    Download Now

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now